News

Article

BD Launches Plunger Stopper in Partnership with Aptar Pharma

Becton, Dickinson, and Company and partner Aptar’s new plunger stopper will support the injection of biologics into subcutaneous tissue.

Becton, Dickinson, and Company (BD)’s BD SCF PremiumCoat Plunger Stopperade in partnership with Aptar Pharma, has been designed to support the injection of biologics into subcutaneous tissue with a -mL pre-filled syringe. BD and Aptar Pharma introduced the new stopper in October 2021.

The plunger stopper uses Aptar Pharma’s rubber formulation and film technology that is designed to limit drug component interactions and ensure drug integrity. According to an Oct. 13, 2021 BD press release, the product is designed to deliver improved functional performance, such as reduced glide force and glide force variability, in combination products. Quality of the stopper is verified in part through BD Viosioguard 100% camera inspection, which aims to ensure the product meets customer specifications and reduce the risk of foreign matter contamination.

“Biologics represent a critical and fast-growing segment of the drug market in the fight against serious diseases,” said Eric Borin, worldwide president of BD Medical-Pharmaceutical Systems, in the press release. “Enhanced biologic combination products are needed to ensure that patients and their caregivers can administer these drugs from the comfort of their homes. This partnership with Aptar Pharma will help deliver on that need.”

“The launch of BD SC PremiumCoat Plunger Stopper, merging BD and Aptar Pharma’s expertise, brings a new generation of coated plunger stopper solutions to the market to support the protection of sensitive drugs by reducing the quantity and species of probable leachables,” said Gabriel Zenker, president, Aptar Pharma Injectables, in the press release. “In partnering with BD, we look forward to furthering our support of biotech companies in their efforts to provide safe and easy-to-use drug delivery systems, while we continue to invest in new technologies to address the evolving needs of [the] market.”

Source: BD

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content